GENWORTH FINANCIAL INC
For the period ended Dec 31, 2025. Filed Feb 27, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 27, 2026
GNW$8.72+0.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
Index to Consolidated Financial Statements
| Page | |
|---|---|
| Annual Financial Statements: | |
| Report of Independent Registered Public Accounting Firm (KPMG LLP, Richmond, VA, Auditor Firm ID: 185) | 111 |
| Financial Statements as of December 31, 2025 and 2024 and for the years ended December 31, 2025, 2024 and 2023: | |
| Consolidated Balance Sheets | 114 |
| Consolidated Statements of Operations | 115 |
| Consolidated Statements of Comprehensive Income (Loss) | 116 |
| Consolidated Statements of Changes in Equity | 117 |
| Consolidated Statements of Cash Flows | 118 |
| Notes to Consolidated Financial Statements: | 119 |
| Note 1 – Nature of Business | 119 |
| Note 2 – Summary of Significant Accounting Policies | 120 |
| Note 3 – Earnings (Loss) Per Share | 135 |
| Note 4 – Investments | 136 |
| Note 5 – Derivative Instruments | 151 |
| Note 6 – Deferred Acquisition Costs | 156 |
| Note 7 – Reinsurance | 156 |
| Note 8 – Future Policy Benefits | 160 |
| Note 9 – Policyholder Account Balances | 165 |
| Note 10 – Additional Insurance Liabilities | 168 |
| Note 11 – Market Risk Benefits | 169 |
| Note 12 – Separate Accounts | 172 |
| Note 13 – Liability for Policy and Contract Claims | 172 |
| Note 14 – Employee Benefit Plans | 175 |
| Note 15 – Borrowings and Other Financings | 177 |
| Note 16 – Income Taxes | 179 |
| Note 17 – Supplemental Cash Flow Information | 182 |
| Note 18 – Long-Term Incentive Compensation | 182 |
| Note 19 – Fair Value of Financial Instruments | 185 |
| Note 20 – Insurance Subsidiary Financial Information and Regulatory Matters | 204 |
| Note 21 – Segment Information | 208 |
| Note 22 – Commitments and Contingencies | 211 |
| Note 23 – Changes in Accumulated Other Comprehensive Income (Loss) | 216 |
| Note 24 – Noncontrolling Interests | 218 |
| Financial Statement Schedules as of December 31, 2025 and 2024 and for the years ended December 31, 2025, 2024 and 2023: | |
| Schedule I, Summary of Investments—Other Than Investments in Related Parties | 219 |
| Schedule II, Condensed Financial Information of Registrant (Parent Company Only) | 220 |
| Schedule III, Supplemental Insurance Information | 225 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.